BlackRock »

Evommune shares owned by BlackRock

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by BlackRock

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4M 142k 17.12

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)

View all positions for BlackRock

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Rtw Investments
Marshall Wace
Eventide Asset Management
Sectoral Asset Management
Verition Fund Management
Standard Life Aberdeen
Velan Capital Investment Management
Vanguard Group
Octagon Capital Advisors
American Century Companies
Federated Investors

View all funds holding Evommune